|
|
|
| | Home | | Journal | | Directories | | Resources | | MAGI | | About Us | | Contact Us | | Sign In | | Sign Up |
EC Directive – Medicinal ProductsDIRECTIVE 2001/83/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF 6 NOVEMBER 2001 ON THE COMMUNITY CODE RELATING TO MEDICINAL PRODUCTS FOR HUMAN USEOfficial Journal L – 311, 28/11/2004, p. 67 – 128 as amended by Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC Official Journal L – 33, 08/02/2003, p. 30 – 40 Directive 2004/24/EC of the European Parliament and the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use Official Journal L – 136, 30/04/2004, p. 85 – 90 Directive 2004/27/EC of the European Parliament and the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use Official Journal L – 136, 30/04/2004, p. 34 – 57. This text does not contain the Annex to Directive 2001/83/EC. The Annex currently in force is laid down in Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Official Journal L 159, 27/6/2003 p. 46 - 94). DISCLAIMER: THIS TEXT IS AN INFORMAL CODIFICATION TO FACILITATE WORK WITH THE RELEVANT LEGISLATION. ONLY THE VERSIONS AS PUBLISHED IN THE OFFICIAL JOURNAL OF THE EUROPEAN COMMUNITY ARE BINDING THE EUROPEAN PARLIAMENT AND THE Having regard to the Treaty establishing the COUNCIL OF THE EUROPEAN UNION, European Community, and in particular Article 95 thereof, Having regard to the Treaty establishing the European Community, and in particular Article 152(4)(a) thereof, [legal basis of Directive 2002/98/EC] Having regard to the proposal from the Commission, Having regard to the opinion of the Economic and Social Committee[1], [1] OJ C 75, 15.3.2000, p. 11. Acting in accordance with the procedure laid down in Article 251 of the Treaty[2], [2] Opinion of the European Parliament of 3 July 2001 (not yet published in the Official Journal) and Council Decision of 27 September 2001. Whereas:
|
| © 2003-2012 First Clinical Research LLC. Trademark Notice Terms & Conditions Privacy Statement Site Map |